人工智能在糖尿病个性化治疗中的伦理挑战与治理策略  

The Ethical Challenge and Governance Strategies of Artificial Intelligence in Personalized Diabetes Treatment

作　　者：侯滢 HOU Ying(College of Humanities and Management,Shaanxi University of Chinese Medicine,Xi'an 712046,China)

机构地区：[1]陕西中医药大学人文管理学院,陕西西安712046

出　　处：《医学与哲学》2024年第23期34-37,48,共5页Medicine and Philosophy

基　　金：2019年陕西省教育厅重点科研计划项目(19JZ029);2020年陕西省重点研发计划项目(2020SF-157);2023年陕西省中医药科研项目(SZY-KJCYC-2023-046);2021年陕西中医药管理局科研项目(2021-GJ-JC001);2023年陕西省教师教育改革与教师发展研究项目(SJS2023YB056);2024年“翱翔之翼”大学生科技志愿服务项目(XMSB20240920009);2023年陕西省大学生创新创业训练计划项目(S202310716037)。

摘　　要：人工智能赋能糖尿病个性化治疗为缓解我国医疗资源紧张、提升糖尿病诊疗效率、实现全周期的远程化管理提供了更好的解决思路。现阶段,糖尿病自我管理系统、糖尿病及并发症智能预测和早筛系统、人工胰腺闭环系统的发展显著提高了治疗精准度和效率,优化了患者自我管理能力,推动了医疗实践的革新。同时,人工智能在该领域的发展也引发了如数据隐私与安全、算法偏见与公平性、知情同意与数据使用透明度、诊疗决策与责任鸿沟等一系列伦理挑战。最后,提出可行的治理策略,旨在关注技术与伦理标准的协调性,实现人工智能在糖尿病个性化治疗中的可持续发展。The application of artificial intelligence(AI)in personalized diabetes treatment provides a better solution to ease the tension of medical resources in China,improve the efficiency of diagnosis and treatment of diabetes,and enable comprehensive remote management.Currently,developments of diabetes self-management system,diabetes and complications intelligent prediction and early screening system,and artificial pancreas closed-loop system have significantly improved the accuracy and efficiency of treatment,optimized patients'self-management ability,and promoted the innovation of medical practice.However,the development of AI in this field has also caused a range of ethical challenges,such as data privacy and security,algorithmic bias and fairness,informed consent and data usage transparency,and the responsibility gap in medical decision-making.This paper attempts to propose feasible governance strategies aimed at harmonizing technical and ethical standards to achieve the sustainable development of AI in personalized diabetes treatment.

关 键 词：糖尿病管理 人工智能 个性化治疗 伦理困境 

分 类 号：R-05[医药卫生]